BRD4 and cancer: In conjunction with the released ARV‐771, the consumption of GSH may not only strengthen the antiproliferative effect of BRD4 proteolysis but also enhance the cytotoxicity triggered by c‐Myc downregulation through a canonical redox‐mediated pathway,[29, 42] highlighting the potential of PDSA nanoparticles in Nano‐PROTACs for cancer therapy.